Photodynamic Therapy and ALA (ALA-PDT)

Written by on August 31, 2005 in laser therapy, PDT with 0 Comments

From Skin & Aging, Volume 13, Issue 3, March 2005, Pages: 42 – 51

The Ever-Increasing Role of ALA-PDT, Part 2

The topical application of 5-amino-levulinic acid (ALA) and exposure to a variety of lasers and light sources and photodynamic therapy (PDT), has become a very popular dermatologic procedure for a variety of clinical concerns affecting our patients. Presently, 20% 5-aminolevulinic acid (Levulan) is the only FDA-approved formulation.ALA-PDT is fast becoming a standard treatment for photorejuvenation with and without actinic keratoses (AKs), acne vulgaris, rosacea, sebaceous gland hyperplasia and hidradenitis suppurativa.

See also

Related Articles

Read more about: laser therapy, PDT

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Discover more from Rosacea Support Group

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.